Child Healthcare Associates

Liverpool, New York 13090

0 studies enrolling now · 2 studies all time

What they study most

Human Metapneumovirus and Human Parainfluenza Infection, Pneumococcal Disease

Studies at this site

• 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants — Completed
• Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure — Completed